Changes of metabolic and inflammatory markers in HIV infection: Glucose, lipids, serum Hs-CRP and myeloperoxidase

Metabolism: Clinical and Experimental

Volumn 61, Issue 10, 2012, Pages 1353-1360

  Borato, Danielle Cristyane Kalva ^a   Parabocz, Gisele Chibinski ^a   Ribas, Sônia Regina Weber ^b   Kalva Filho, Carlos Augusto ^c   Borba, Luciana Maria ^a   Ito, Carmen Antonia Sanches ^a   Bail, Larissa ^a   Dos Santos, Fábio André ^a   Vellosa, José Carlos Rebuglio ^a  

^a STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

^b Expert Assistance Service (EAS)   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CELL COUNT; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD GLUCOSE; C-REACTIVE PROTEIN; FEMALE; HIV INFECTIONS; HUMANS; LIPIDS; MALE; MIDDLE AGED; PEROXIDASE;

EID: 84866738601     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.03.003     Document Type: Article

References (41)

1. F.J. Palella Jr Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators N Engl J Med 338 13 1998 853 860 (Pubitemid 28135961)
2. P.Y. Hsue Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection Circulation 109 13 2004 1603 1608
3. J.V. Baker, and J.D. Lundgren Cardiovascular implications from untreated human immunodeficiency virus infection Eur Heart J 32 8 2011 945 951
4. K. Mondy, and P. Tebas Cardiovascular risks of antiretroviral therapies Annu Rev Med 58 2007 141 155 (Pubitemid 46706506)
5. E. Anuurad, A. Semrad, and L. Berglund Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease Metab Syndr Relat Disord 7 5 2009 401 410
6. M.P. Dube Relationship of body composition, metabolic status, antiretroviral use, and HIV disease factors to endothelial dysfunction in HIV-infected subjects AIDS Res Hum Retroviruses 26 8 2010 847 854
7. L. Calza Prevalence of diabetes mellitus, hyperinsulinaemia and metabolic syndrome among 755 adult patients with HIV-1 infection Int J STD AIDS 22 1 2011 43 45
8. B. Capili, J.K. Anastasi, and O. Ogedegbe HIV and general cardiovascular risk J Assoc Nurses AIDS Care 2011 10.1016/j.jana.2010.12.002
9. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 2 1999 115 126 (Pubitemid 29054847)
10. M. Weber, and C. Hamm Novel biomarkers - the long march from bench to bedside Eur Heart J 29 9 2008 1079 1081 (Pubitemid 351844897)
11. D.A. Morrow Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 Eur Heart J 29 9 2008 1096 1102 (Pubitemid 351844877)
12. C.M. Nagesh, and A. Roy Role of biomarkers in risk stratification of acute coronary syndrome Indian J Med Res 132 5 2010 627 633
13. D. Chan, and L.L. Ng Biomarkers in acute myocardial infarction BMC Med 8 2010 34 10.1186/1741-7015-8-34
14. M.L. Brennan Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 17 2003 1595 1604
15. S.J. Nicholls, and S.L. Hazen Myeloperoxidase, modified lipoproteins, and atherogenesis J Lipid Res 50 2009 S346 S351
16. R. Zhang Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 17 2001 2136 2142 (Pubitemid 34041599)
17. S. Baldus Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes Circulation 108 12 2003 1440 1445 (Pubitemid 37176448)
18. V. Rudolph Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction Int J Cardiol 2010 10.1016/j.ijcard.2010.08.015
19. B. Ikitimur, and B. Karadag Role of myeloperoxidase in cardiology Future Cardiol 6 5 2010 693 702
20. W.H. Tang Plasma myeloperoxidase predicts incident cardiovascular risks in stable patients undergoing medical management for coronary artery disease Clin Chem 57 1 2011 33 39
21. M. Saito Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors Atherosclerosis 167 1 2003 73 79 (Pubitemid 36255637)
22. R.V. Sekhar Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study Metab Clin Exp 60 6 2011 754 760
23. J. Oh, and R.A. Hegele HIV-associated dyslipidaemia: pathogenesis and treatment Lancet Infect Dis 7 12 2007 787 796 (Pubitemid 350153668)
24. P.T. Williams, and D.E. Feldman Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort Atherosclerosis 214 1 2011 196 202
25. S. De Wit Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study Diabetes Care 31 6 2008 1224 1229
26. S.B. Haugaard Impaired proinsulin secretion before and during oral glucose stimulation in HIV-infected patients who display fat redistribution Metab Clin Exp 56 7 2007 939 946 (Pubitemid 46890977)
27. H. Rose HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment Metab Clin Exp 55 1 2006 90 95 (Pubitemid 41736252)
28. M. Masia The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patients Atherosclerosis 195 1 2007 167 171 (Pubitemid 47569983)
29. M.M. Guimaraes High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection Atherosclerosis 201 2 2008 434 439
30. U. Oliviero Human immunodeficiency virus per se exerts atherogenic effects Atherosclerosis 204 2 2009 586 589
31. A.C. Ross Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy Clin Infect Dis 49 7 2009 1119 1127
32. D. El-Bejjani Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults HIV Clin Trials 9 3 2008 207 211 (Pubitemid 351892875)
33. M.P. St-Onge Baseline inflammatory markers do not modulate the lipid response to weight loss Metab Clin Exp 57 5 2008 598 604
34. L.P. Zwan Plasma myeloperoxidase is inversely associated with endothelium-dependent vasodilation in elderly subjects with abnormal glucose metabolism Metab Clin Exp 59 12 2010 1723 1729
35. M.C. Meuwese Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study J Am Coll Cardiol 50 2 2007 159 165 (Pubitemid 47002189)
36. N. Friis-Moller Combination antiretroviral therapy and the risk of myocardial infarction N Engl J Med 349 21 2003 1993 2003
37. N. Friis-Moller Class of antiretroviral drugs and the risk of myocardial infarction N Engl J Med 356 17 2007 1723 1735 (Pubitemid 46658704)
38. S. Tsiodras, and C.S. Mantzoros Drug-drug interactions in HIV medicine: a not so simple and straightforward road to the future. Metab Clin Exp 60 11 2011 1497 1499
39. F. Magkos, and C.S. Mantzoros Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment Metab Clin Exp 60 6 2011 749 753
40. F. Magkos Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study Metab Clin Exp 60 7 2011 1045 1049
41. R. Rossi Metabolic disorders induced by highly active antiretroviral therapy and their relationship with vascular remodeling of the brachial artery in a population of HIV-infected patients Metab Clin Exp 58 7 2009 927 933